Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy.
Anna M Mc Laughlin, Cassian Yee
Author Information
- Anna M Mc Laughlin: Pharmetheus AB, Uppsala, Sweden anna.mclaughlin@pharmetheus.com. ORCID
- Cassian Yee: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ORCID
No abstract text available.
- Clin Pharmacol Ther. 2022 Nov;112(5):968-981
[PMID: 34888856]
- J Immunother Cancer. 2022 Dec;10(12):
[PMID: 36600553]
- J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):623-638
[PMID: 34159497]
- Blood Adv. 2020 Oct 13;4(19):4898-4911
[PMID: 33035333]
- Nat Comput Sci. 2022 Dec;2(12):785-796
[PMID: 38126024]
- Cancers (Basel). 2021 Jun 03;13(11):
[PMID: 34205020]
Humans
Receptors, Chimeric Antigen
Immunotherapy, Adoptive
Receptors, Antigen, T-Cell
Cell- and Tissue-Based Therapy
Computer Simulation
Receptors, Chimeric Antigen
Receptors, Antigen, T-Cell
